Literature DB >> 7815789

Carcinoma of the esophagus. Prognostic significance of histologic type.

M D Lieberman1, C D Shriver, S Bleckner, M Burt.   

Abstract

Previous investigators have reported that in patients with esophageal carcinoma tumor cell type affects prognosis. A retrospective analysis of 258 patients, from 1985 to 1991, undergoing curative esophagogastrectomy for adenocarcinoma (n = 134) or squamous cell carcinoma (n = 124) was performed to test the hypothesis that histologic cell type is an independent prognostic factor and to identify other predictors of survival after resection. The actuarial overall survival (p = 0.16) and disease-specific survival (p = 0.68) were similar for adenocarcinoma (median overall survival = 27 months) and squamous cell carcinoma (median overall survival = 22 months). Univariate analysis identified T stage, N stage, number of diseased nodes, tumor differentiation, tumor site, and blood transfusions as significant (p < 0.05) variables in predicting overall survival. The presence of Barrett's esophagus was not predictive of survival. Multivariate analysis demonstrated that T stage (p = 0.006), N stage (p = 0.01), and number of diseased lymph nodes (p = 0.03) were independent predictors of overall survival. This analysis demonstrated that histologic type is not an independent variable for overall survival in patients undergoing curative esophagogastrectomy for carcinoma of the esophagus and gastroesophageal junction. Outcome is most strongly influenced by extent of disease defined by T and N stage.

Entities:  

Mesh:

Year:  1995        PMID: 7815789     DOI: 10.1016/S0022-5223(95)70428-0

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  22 in total

1.  ACP. Best Practice No 155. Guidelines for handling oesophageal biopsies and resection specimens and their reporting.

Authors:  N B Ibrahim
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

2.  Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma.

Authors:  Christophe Mariette; Laetitia Finzi; Guillaume Piessen; Isabelle Van Seuningen; Jean Pierre Triboulet
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

3.  Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer.

Authors:  S P Dexter; H Sue-Ling; M J McMahon; P Quirke; N Mapstone; I G Martin
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

4.  Should en bloc esophagectomy be the standard of care for esophageal carcinoma?

Authors:  N Altorki; D Skinner
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

Review 5.  Preoperative chemotherapy for resectable thoracic esophageal cancer.

Authors:  Biniam Kidane; Shaun Coughlin; Kelly Vogt; Richard Malthaner
Journal:  Cochrane Database Syst Rev       Date:  2015-05-19

Review 6.  Transhiatal versus transthoracic esophagectomy for esophageal cancer.

Authors:  J Camilo Barreto; Mitchell C Posner
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

7.  The role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer.

Authors:  Fergus Noble; James Hopkins; Nathan Curtis; Jamie J Kelly; Ian S Bailey; James P Byrne; Adrian C Bateman; Andrew R Bateman; Timothy J Underwood
Journal:  Med Oncol       Date:  2013-05-21       Impact factor: 3.064

8.  Basaloid squamous cell cancer arising in Barrett's esophagus.

Authors:  Neeraj Kaushik; Debra Brody; Neil Christie; Kevin McGrath
Journal:  Int J Gastrointest Cancer       Date:  2003

9.  Consensus statement of the Hellenic and Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management of oesophageal cancer.

Authors:  Andreas Fountoulakis; John Souglakos; Louiza Vini; Gerasimos N Douridas; Anna Koumarianou; Panteleimon Kountourakis; Christos Agalianos; Andreas Alexandrou; Christos Dervenis; Sofia Gourtsoyianni; Nikolaos Gouvas; Maria-Angeliki Kalogeridi; Georgia Levidou; Theodoros Liakakos; Joseph Sgouros; Spiros N Sgouros; Charikleia Triantopoulou; Evangelos Xynos
Journal:  Updates Surg       Date:  2019-12-02

Review 10.  Surgical indications and optimization of patients for resectable esophageal malignancies.

Authors:  Joshua C Grimm; Vicente Valero; Daniela Molena
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.